Company Filing History:
Years Active: 2020
Title: Anna Splanemann: Innovator in Human Growth Hormone Prodrugs
Introduction
Anna Splanemann is a prominent inventor based in Heidelberg, Germany. She has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative drug formulations. Her work focuses on enhancing the efficacy of human growth hormone treatments.
Latest Patents
Anna Splanemann holds a patent for "Polymeric hGH prodrugs." This invention relates to a polymeric human growth hormone prodrug and includes dry, liquid, and reconstituted pharmaceutical formulations comprising said prodrug. The patent also discusses their use as medicaments for treating diseases that can be addressed with growth hormone, along with methods of treatment and application of such formulations.
Career Highlights
Anna is currently employed at Ascendis Pharma Endocrinology Division, where she continues to advance her research and development efforts. Her innovative approach has positioned her as a key player in the pharmaceutical industry, particularly in the area of endocrinology.
Collaborations
Anna collaborates with notable colleagues, including Thomas Kurpiers and Harald Rau. Their combined expertise contributes to the success of their projects and enhances the impact of their work in the field.
Conclusion
Anna Splanemann is a trailblazer in the development of polymeric human growth hormone prodrugs, with a focus on improving treatment options for patients. Her contributions to the pharmaceutical industry are noteworthy and continue to influence advancements in medical science.